Purpura fulminans. A fatal consequence of a widely used medication?;Purpura fulminans: Fatale folge einer alltäglichen therapie?

Hautarzt

Volumn 53, Issue 7, 2002, Pages 483-487

  Hengge, U R ^a   Jochum, C ^b   Tschakarjan, E ^a   Maschke, J ^a   Erbel, R ^b   Schmid, K W ^c   Otterbach, F ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Medizinischen Klinik   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Diclofenac; Disseminated intravascular coagulopathy; Infection; Intoxication; Purpura fulminans; Stevens Johnson syndrome

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; FULMINATING PURPURA; HUMAN; MALE; PATHOGENESIS; RHABDOMYOLYSIS; STEVENS JOHNSON SYNDROME;

EID: 0036935599     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-002-0346-8     Document Type: Article

References (25)

1. Darmstadt GL (1998) Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 15:169-183
2. Andreasen TJ, Green SD, Childers BJ (2001) Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg 107:1025-1035
3. Francis RB Jr (1990) Acquired purpura fulminans. Semin Thromb Hemost 16:310-325
4. Nolan J, Sinclair R (2001) Review of management of purpura fulminans and two case reports. Br J Anaesth 86:581-586
5. Adcock DM, Brozna J, Marlar RA (1990) Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis. Semin Thromb Hemost 16:333-340
6. Marlar RA, Neumann A (1990) Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 16:299-309
7. Madden RM, Gill JC, Marlar RA (1990) Protein C and protein S levels in two patients with acquired purpura fulminans. Br J Haematol 75:112-117
8. Herrera R, Hobar PC, Ginsburg CM (1994) Surgical intervention for the complications of meningococcal-induced purpura fulminans. Pediatr Infect Dis J 13:734-737
9. Kato N, Morioka T (1991) Purpura fulminans secondary to Xanthomonas maltophilia sepsis in an adult with aplastic anemia. J Dermatol 18:225-229, 34-737
10. Dollberg S, Nachum Z, Klar A et al. (1992) Haemophilus influenzae type b purpura fulminans treated with hyperbaric oxygen. J Infect 25:197-200
11. Adcock DM, Hicks MJ (1990) Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemost 16:283-292
12. Sheridan RL, Briggs SE, Remensnyder JP, Tompkins RG (1996) Management strategy in purpura fulminans with multiple organ failure in children. Burns 22:53-56
13. Majeski JA, Alexander JW (1983) Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg 145:784-787
14. Chasan PE, Hansbrough JF, Cooper ML (1992) Management of cutaneous manifestations of extensive purpura fulminans in a burn unit. J Burn Care Rehabil 13:410-413
15. Brown DL, Greenhalgh DG, Warden GD (1998) Purpura fulminans: a disease best managed in a burn center. J Burn Care Rehabil 19:119-123
16. Besner GE, Klamar JE (1998) Integra artificial skin as a useful adjunct in the treatment of purpura fulminans. J Burn Care Rehabil 19:324-329
17. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96
18. Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272-1285
19. O'Brien WM (1986) Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs. Am J Med 80:70-80
20. Mahboob A, Haroon TS (1998) Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. 37:833-838
21. Matsuo H, Ashihara H, Harashima H, Ukita Y, Fukuki S (1997) Case of Reye's syndrome with multiple organ failure induced by diclofenac sodium. Nippon Naika Gakkai Zasshi 86:1254-1256
22. Claros Gonzalez I, Banos Gallardo M, Casal Alvarez F, Arguelles Torano M (1989) Systemic thrombotic microangiopathy secondary to diclofenac. Med Clin (Barc) 92:396
23. Delrio FG, Park Y, Herzlich B, Grob D (1996) Case report: diclofenac-induced rhabdomyolysis. Am J Med Sci 312:95-97
24. Seigneuric C, Nougue J, Plantavid M (1982) Erythema multiforme with mucous membrane involvement: responsibility of diclofenac? Ann Dermatol Venereol 109:287
25. Sanchez Yus E, Requena L, Simon P (1993) Histopathology of cutaneous changes in drug-induced coma. Am J Dermatopathol 15:208-216